Guacetisal

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Guacetisal" – news · newspapers · books · scholar · JSTOR (November 2023) (Learn how and when to remove this message)

Guacetisal

Clinical data
Trade names	Broncaspin; Balsacetil; Guaiaspir; Prontomucil
Other names	Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate
ATC code	N02BA14 (WHO)
Identifiers
IUPAC name 2-Methoxyphenyl 2-acetoxybenzoate
CAS Number	55482-89-8
PubChem CID	68749
ChemSpider	61994
UNII	T6EKB9V2O2
ChEMBL	ChEMBL2105097
CompTox Dashboard (EPA)	DTXSID40204060
ECHA InfoCard	100.054.221
Chemical and physical data
Formula	C16H14O5
Molar mass	286.283 g·mol−1
3D model (JSmol)	Interactive image
Melting point	72 to 74.5 °C (161.6 to 166.1 °F)
SMILES O=C(Oc1ccccc1C(=O)Oc2ccccc2OC)C
InChI InChI=1S/C16H14O5/c1-11(17)20-13-8-4-3-7-12(13)16(18)21-15-10-6-5-9-14(15)19-2/h3-10H,1-2H3 Key:HSJFYRYGGKLQBT-UHFFFAOYSA-N

Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.^[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.^{[citation needed]}